Literature DB >> 17406520

Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients.

Trevor G Shepherd1, Brigitte L Thériault, Elizabeth J Campbell, Mark W Nachtigal.   

Abstract

Our laboratory has refined the technique for isolating primary cultures of normal human ovarian surface epithelial (OSE) cells by combining two different protocols involving the enzymatic and mechanical removal of OSE cells from ovarian biopsies. A simple protocol of obtaining primary epithelial ovarian cancer (EOC) cells from the ascites fluid removed from patients with high-grade ovarian cancer is also described. These methods allow for the direct application of many molecular and cellular analyses of normal versus cancer cells isolated freshly from patients, with the added potential for retrospective analyses of archived cells and tissues. Thus, we have included optional steps for the immediate preparation of ascites-derived EOC cells to be used for subsequent cytological analyses. Initial isolation of OSE or EOC cells can be completed in 1 h, and primary cells are further expanded in culture for several weeks.

Entities:  

Mesh:

Year:  2006        PMID: 17406520     DOI: 10.1038/nprot.2006.328

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  70 in total

1.  Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.

Authors:  Rohann J M Correa; Monica Komar; Jessica G K Tong; Milani Sivapragasam; Masmudur M Rahman; Grant McFadden; Gabriel E Dimattia; Trevor G Shepherd
Journal:  Gynecol Oncol       Date:  2012-02-01       Impact factor: 5.482

2.  Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics.

Authors:  Danielle N Van; Charlotte F Roberts; James D Marion; Sandrine Lépine; Kuzhuvelil B Harikumar; Jessica Schreiter; Catherine I Dumur; Xianjun Fang; Sarah Spiegel; Jessica K Bell
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

Review 3.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

4.  Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells.

Authors:  Rafaela Erices; Maria Loreto Bravo; Pamela Gonzalez; Bárbara Oliva; Dusan Racordon; Marcelo Garrido; Carolina Ibañez; Sumie Kato; Jorge Brañes; Javier Pizarro; Maria Isabel Barriga; Alejandro Barra; Erasmo Bravo; Catalina Alonso; Eva Bustamente; Mauricio A Cuello; Gareth I Owen
Journal:  Reprod Sci       Date:  2013-05-07       Impact factor: 3.060

5.  Method for obtaining primary ovarian cancer cells from solid specimens.

Authors:  Lee J Pribyl; Kathleen A Coughlin; Thanasak Sueblinvong; Kristin Shields; Yoshie Iizuka; Levi S Downs; Rahel G Ghebre; Martina Bazzaro
Journal:  J Vis Exp       Date:  2014-02-04       Impact factor: 1.355

6.  Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.

Authors:  Rohann J M Correa; Yudith Ramos Valdes; Teresa M Peart; Elena N Fazio; Monique Bertrand; Jacob McGee; Michel Préfontaine; Akira Sugimoto; Gabriel E DiMattia; Trevor G Shepherd
Journal:  Carcinogenesis       Date:  2014-02-22       Impact factor: 4.944

7.  Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion.

Authors:  Trevor G Shepherd; Michelle L Mujoomdar; Mark W Nachtigal
Journal:  J Ovarian Res       Date:  2010-02-26       Impact factor: 4.234

8.  Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.

Authors:  R Kar; J K Palanichamy; A Banerjee; P Chattopadhyay; S K Jain; N Singh
Journal:  Clin Transl Oncol       Date:  2015-06-02       Impact factor: 3.405

Review 9.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

10.  Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.

Authors:  Mi Jeong Kwon; Sung-Su Kim; Yoon-La Choi; Hun Soon Jung; Curt Balch; Su-Hyeong Kim; Yong-Sang Song; Victor E Marquez; Kenneth P Nephew; Young Kee Shin
Journal:  Carcinogenesis       Date:  2010-01-06       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.